1. A. Protocol:

   1. (1) Prescriptive authority for Tuberculosis (TB) testing shall be exercised solely in accordance with the written protocol for TB testing drug therapy approved by the board.
   2. (2) Any pharmacist exercising prescriptive authority for TB testing must maintain a current copy of the written protocol for TB testing approved by the board.

2. B. Education and training:

   1. (1) The pharmacist must successfully complete training as specified by the New Mexico department of health tuberculosis department provided by:

      1. (a) the department of health or;
      2. (b) a similar health authority or professional body approved by the board.
   2. (2) Continuing education: Any pharmacist exercising prescriptive authority for TB testing shall complete continuing education as specified by the centers for disease control.

3. C. Authorized drugs:

   1. (1) TB skin antigen serum(s).
   2. (2) Prescriptive authority for TB testing shall be limited to those drugs delineated in the written protocol approved by the board.

4. D. Records:

   1. (1) The prescribing pharmacist must generate a written or electronic prescription for any TB test administered.
   2. (2) Informed consent must be documented in accordance with the approved protocol for TB testing and a record of such consent maintained in the pharmacy for a period of at least three years.
5. E. Notification: Upon signed consent of the patient, the pharmacist shall notify the patient’s designated physician or primary care provider and the department of health of any positive TB test.

[16.19.26.12 NMAC - N, 3/7/2011; A, 9/6/2015; Rn. & A 16.19.26.11 NMAC, 5/31/2021]